Emil Freireich

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Cultured Tumor Cells

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tsimberidou Apostolia-Maria; Wen Sijin; McLaughlin Peter; O'Brien Susan; Wierda William G; Lerner Susan; Strom Sara; Freireich Emil J; Medeiros L Jeffrey; Kantarjian Hagop M; Keating Michael J
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Freireich Emil J; Kurzrock Razelle
The role of investigational therapy in management of patients with advanced metastatic malignancy.
Freireich Emil J; Kantarjian Hagop; Keating Michael J
Leukemia research, 2008.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Emil Freireich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tsimberidou Apostolia-Maria; Wen Sijin; McLaughlin Peter; O'Brien Susan; Wierda William G; Lerner Susan; Strom Sara; Freireich Emil J; Medeiros L Jeffrey; Kantarjian Hagop M; Keating Michael J
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):904-10.
2009: Freireich Emil J; Kurzrock Razelle
The role of investigational therapy in management of patients with advanced metastatic malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):304-6.
2009: Freireich Emil J; Kantarjian Hagop; Keating Michael J
Leukemia research, 2008.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S178.
2008: Freireich Emil J
Rethinking the randomized clinical trial: the 21st century application of Freireich's laws. [An interview with Emil J Freireich by H&O].
Clinical advances in hematology & oncology : H&O 2008;6(11):801-4.
2008: Kantarjian Hagop; O'Brien Susan; Cortes Jorge; Wierda William; Faderl Stefan; Garcia-Manero Guillermo; Issa Jean-Pierre; Estey Elihu; Keating Michael; Freireich Emil J
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.
Cancer 2008;113(7 Suppl):1933-52.
2008: Tsimberidou Apostolia-Maria; Kantarjian Hagop M; Wen Sijin; Keating Michael J; O'Brien Susan; Brandt Mark; Pierce Sherry; Freireich Emil J; Medeiros L Jeffrey; Estey Elihu
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.
Cancer 2008;113(6):1370-8.
2008: Kantarjian Hagop; O'Brien Susan; Ravandi Farhad; Cortes Jorge; Shan Jianqin; Bennett John M; List Alan; Fenaux Pierre; Sanz Guillermo; Issa Jean-Pierre; Freireich Emil J; Garcia-Manero Guillermo
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.
Cancer 2008;113(6):1351-61.
2008: Tsimberidou Apostolia-Maria; Kantarjian Hagop M; Wen Sijin; O'Brien Susan; Cortes Jorge; Wierda William G; Koller Charles; Pierce Sherry; Brandt Mark; Freireich Emil J; Keating Michael J; Estey Elihu H
The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):721-30.
2007: Atallah Ehab; Cortes Jorge; O'Brien Susan; Pierce Sherry; Rios Mary Beth; Estey Elihu; Markman Maurie; Keating Michael; Freireich Emil J; Kantarjian Hagop
Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia.
Blood 2007;110(10):3547-51.
2007: Tsimberidou Apostolia M; Wen Sijin; O'Brien Susan; McLaughlin Peter; Wierda William G; Ferrajoli Alessandra; Faderl Stefan; Manning John; Lerner Susan; Mai Chinh V; Rodriguez Alma M; Hess Mark; Do Kim-Anh; Freireich Emil J; Kantarjian Hagop M; Medeiros L Jeffrey; Keating Michael J
Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4648-56.
2007: Freireich Emil J
Should terminally ill patients have the right to take drugs that pass phase I testing? Yes.
BMJ (Clinical research ed.) 2007;335(7618):478.
2006: Bodey Gerald Paul; Freireich Emil J
Influence of high-efficiency particulate air filtration on mortality and fungal infection: a rebuttal.
The Journal of infectious diseases 2006;194(11):1621-2; author reply 1622-3.
2006: Verstovsek Srdan; Giles Francis; Quintás-Cardama Alfonso; Perez Nichole; Ravandi-Kashani Farhad; Beran Miloslav; Freireich Emil; Kantarjian Hagop
Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
Hematological oncology 2006;24(4):181-8.
2006: Yothers Greg; Wieand Samuel; Freireich Emil J
Randomization in Phase II Clinical Trials.
Clinical advances in hematology & oncology : H&O 2006;4(10):776-8.
2006: Montero Alberto J; Estrov Zeev; Freireich Emil J; Khouri Issa F; Koller Charles A; Kurzrock Razelle
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome.
Leukemia & lymphoma 2006;47(10):2049-54.
2006: Safdar Amar; Rodriguez Gilhen H; Lichtiger Benjamin; Dickey Burton F; Kontoyiannis Dimitrios P; Freireich Emil J; Shpall Elizabeth J; Raad Issam I; Kantarjian Hagop M; Champlin Richard E
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Cancer 2006;106(12):2664-71.
2006: Ravandi Farhad; Jorgensen Jeffrey L; O'Brien Susan M; Verstovsek Srdan; Koller Charles A; Faderl Stefan; Giles Francis J; Ferrajoli Alessandra; Wierda William G; Odinga Shirley; Huang Xuelin; Thomas Deborah A; Freireich Emil J; Jones Dan; Keating Michael J; Kantarjian Hagop M
Eradication of minimal residual disease in hairy cell leukemia.
Blood 2006;107(12):4658-62.
2006: Tsimberidou Apostolia-Maria; O'Brien Susan; Khouri Issa; Giles Francis J; Kantarjian Hagop M; Champlin Richard; Wen Sijin; Do Kim-Anh; Smith Susan C; Lerner Susan; Freireich Emil J; Keating Michael J
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2343-51.
2006: Freireich Emil J
The investigational new drug application--who benefits?
Nature clinical practice. Oncology 2006;3(2):62-3.
2005: Saba Rashid; Jabbour Elias; Giles Francis; Cortes Jorge; Talpaz Moshe; O'Brien Susan; Freireich Emil J; Garcia-Manero Guillermo; Kantarjian Hagop; Verstovsek Srdan
Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986.
Cancer 2005;103(12):2551-7.
2005: Freireich Emil J; Kurzrock Razelle; Estrov Zeev
Metastasis--an alternative hypothesis.
Cancer 2005;103(8):1537-9.
2004: Safdar Amar; Hanna Hend A; Boktour Maha; Kontoyiannis Dimitrios P; Hachem Ray; Lichtiger Benjamin; Freireich Emil J; Raad Issam I
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Cancer 2004;101(12):2859-65.
2004: Kantarjian Hagop; Thomas Deborah; O'Brien Susan; Cortes Jorge; Giles Francis; Jeha Sima; Bueso-Ramos Carlos E; Pierce Sherry; Shan Jianqin; Koller Charles; Beran Miloslav; Keating Michael; Freireich Emil J
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Cancer 2004;101(12):2788-801.
2004: Rogers Anna; Joe Youngson; Manshouri Taghi; Dey Amanda; Jilani Iman; Giles Francis; Estey Elihu; Freireich Emil; Keating Michael; Kantarjian Hagop; Albitar Maher
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.
Blood 2004;103(7):2799-801.
2004: Orsolic Nada; Giles Francis J; Gourdeau Henriette; Golemovic Mirna; Beran Miloslav; Cortes Jorge; Freireich Emil J; Kantarjian Hagop; Verstovsek Srdan
Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation.
British journal of haematology 2004;124(6):727-38.
2003: Kurzrock Razelle; Kantarjian Hagop M; Cortes Jorge E; Singhania Neil; Thomas Deborah A; Wilson Edward F; Wright John J; Freireich Emil J; Talpaz Moshe; Sebti Saïd M
Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting.
Blood 2003;102(13):4527-34.
2003: Pearlman Michael; Jendiroba David; Pagliaro Lance; Keyhani Afsaneh; Liu Baoshun; Freireich Emil J; Travis Elizabeth
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.
Cancer chemotherapy and pharmacology 2003;52(6):477-81.
2003: Kantarjian Hagop; Gandhi Varsha; Cortes Jorge; Verstovsek Srdan; Du Min; Garcia-Manero Guillermo; Giles Francis; Faderl Stefan; O'Brien Susan; Jeha Sima; Davis Jan; Shaked Zeev; Craig Adam; Keating Michael; Plunkett William; Freireich Emil J
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Blood 2003;102(7):2379-86.
2003: O'Brien Susan; Giles Francis; Talpaz Moshe; Cortes Jorge; Rios Mary Beth; Shan Jianqin; Thomas Deborah; Andreeff Michael; Kornblau Steven; Faderl Stefan; Garcia-Manero Guillermo; White Kevin; Mallard Susie; Freireich Emil; Kantarjian Hagop M
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
Cancer 2003;98(5):888-93.
2003: Kantarjian Hagop; O'Brien Susan; Cortes Jorge; Giles Francis; Thomas Deborah; Kornblau Steven; Shan Jianquin; Beth Rios Mary; Keating Michael; Freireich Emil; Talpaz Moshe
Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.
Cancer 2003;98(1):81-5.
2003: Pearlman Michael; Jendiroba David; Pagliaro Lance; Keyhani Afsaneh; Liu Baoshun; Freireich Emil J
Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines.
Leukemia research 2003;27(7):617-26.
2003: Cortes Jorge; Giles Francis; O'Brien Susan; Thomas Deborah; Garcia-Manero Guillermo; Rios Mary Beth; Faderl Stefan; Verstovsek Srdan; Ferrajoli Alessandra; Freireich Emil J; Talpaz Moshe; Kantarjian Hagop
Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha.
Blood 2003;102(1):83-6.
2003: Duzkale Hatice; Pagliaro Lance C; Rosenblum Michael G; Varan Ali; Liu Baoshun; Reuben James; Wierda William G; Korbling Martin; McMannis John D; Glassman Armand B; Scheinberg David A; Freireich Emil J
Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(6):364-72.
2003: Duzkale Hatice; Jilani Iman; Orsolic Nada; Zingaro Ralph A; Golemovic Mirna; Giles Francis J; Kantarjian Hagop; Albitar Maher; Freireich Emil J; Verstovsek Srdan
In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.
Cancer chemotherapy and pharmacology 2003;51(5):427-32.
2003: Kantarjian Hagop M; O'Brien Susan; Cortes Jorge E; Shan Jianqin; Giles Francis J; Rios Mary Beth; Faderl Stefan H; Wierda William G; Ferrajoli Alessandra; Verstovsek Srdan; Keating Michael J; Freireich Emil J; Talpaz Moshe
Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis.
Cancer 2003;97(4):1033-41.
2002: Huh Y O; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(11):2249-52.
2002: Jilani Iman; Estey Elihu; Huh Yang; Joe Youngson; Manshouri Taghi; Yared Marwan; Giles Francis; Kantarjian Hagop; Cortes Jorge; Thomas Deborah; Keating Michael; Freireich Emil; Albitar Maher
Differences in CD33 intensity between various myeloid neoplasms.
American journal of clinical pathology 2002;118(4):560-6.
2002: Freireich Emil J
Min Chiu Li: a perspective in cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2764-5.
2002: Albitar Maher; Manshouri Taghi; Shen Yu; Liu Diane; Beran Miloslav; Kantarjian Hagop M; Rogers Anna; Jilani Iman; Lin Chung Wu; Pierce Sherry; Freireich Emil J; Estey Elihu H
Myelodysplastic syndrome is not merely "preleukemia".
Blood 2002;100(3):791-8.
2002: Kantarjian Hagop M; Talpaz Moshe; O'Brien Susan; Smith Terry L; Giles Francis J; Faderl Stefan; Thomas Deborah A; Garcia-Manero Guillermo; Issa Jean-Pierre J; Andreeff Michael; Kornblau Steven M; Koller Charles; Beran Milosav; Keating Michael; Rios Mary Beth; Shan Jenny; Resta Debra; Capdeville Renaud; Hayes Kimberly; Albitar Maher; Freireich Emil J; Cortes Jorge E
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2177-87.
2002: Jendiroba David B; Klostergaard Jim; Keyhani Afsaneh; Pagliaro Lance; Freireich Emil J
Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine.
Leukemia research 2002;26(3):301-10.
2001: Aboul-Nasr R; O'Brien S; Freireich E J; Ginsberg C F; Kantarjian H M; Koller C A; Keating M J; Albitar M
"T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow.
Leukemia & lymphoma 2001;42(5):1023-31.
2001: Freireich E J
Can we conquer cancer in the twenty-first century?
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S4-10.
2001: Verstovsek S; Kantarjian H; Aguayo A; Manshouri T; Freireich E; Keating M; Estey E; Albitar M
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome.
British journal of haematology 2001;114(2):290-5.
2001: Verstovsek S; Kantarjian H; Estey E; Aguayo A; Giles F J; Manshouri T; Koller C; Estrov Z; Freireich E; Keating M; Albitar M
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1165-70.
2001: Keyhani A; Jendiroba D B; Freireich E J
Angiogenesis and leukemia.
Leukemia research 2001;25(8):639-45.
2001: Estey E; Koller C; Cortes J; Reed P; Freireich E; Giles F; Kantarjian H
Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid.
Leukemia & lymphoma 2001;42(3):309-16.
2001: Giles F J; Shen Y; Kantarjian H M; Korbling M J; O'Brien S; Anderlini P; Donato M; Pierce S; Keating M J; Freireich E J; Estey E
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival.
Leukemia & lymphoma 2001;42(1-2):67-73.
2001: Kurzrock R; Bueso-Ramos C E; Kantarjian H; Freireich E; Tucker S L; Siciliano M; Pilat S; Talpaz M
BCR rearrangement-negative chronic myelogenous leukemia revisited.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2915-26.
2001: Ferrajoli A; Manshouri T; Estrov Z; Keating M J; O'Brien S; Lerner S; Beran M; Kantarjian H M; Freireich E J; Albitar M
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):795-9.
2001: O'Brien S M; Kantarjian H; Thomas D A; Giles F J; Freireich E J; Cortes J; Lerner S; Keating M J
Rituximab dose-escalation trial in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2165-70.
2000: Jendiroba D B; Freireich E J
Granulocyte transfusions: from neutrophil replacement to immunereconstitution.
Blood reviews 2000;14(4):219-27.
2000: Freireich E J
Supportive care for patients with blood disorders.
British journal of haematology 2000;111(1):68-77.
2000: Kozuch P; Talpaz M; Faderl S; O'Brien S; Freireich E J; Kantarjian H
Avascular necrosis of the femoral head in chronic myeloid leukemia patients treated with interferon-alpha: a synergistic correlation?
Cancer 2000;89(7):1482-9.
2000: Aguayo A; Kantarjian H; Manshouri T; Gidel C; Estey E; Thomas D; Koller C; Estrov Z; O'Brien S; Keating M; Freireich E; Albitar M
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Blood 2000;96(6):2240-5.
2000: Albitar M; Freireich E J
Molecular defects in chronic myeloproliferative disorders.
Molecular medicine (Cambridge, Mass.) 2000;6(7):555-67.
2000: Ravandi-Kashani F; O'Brien S; Manshouri T; Lerner S; Sim S; Dodd K; Kantarjian H; Freireich E; Keating M; Albitar M
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
Leukemia research 2000;24(6):469-74.
2000: Huh Y O; Smith T L; Collins P; Bueso-Ramos C; Albitar M; Kantarjian H M; Pierce S A; Freireich E J
Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
Leukemia & lymphoma 2000;37(3-4):319-31.
2000: Keating M J; Smith T L; Lerner S; O'Brien S; Robertson L E; Kantarjian H; Freireich E J
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia.
Leukemia & lymphoma 2000;37(1-2):71-85.
2000: Chung C Y; Kantarjian H; Haidar M; Starostik P; Manshouri T; Gidel C; Freireich E; Keating M; Albitar M
Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
Cancer 2000;88(6):1359-64.
2000: Haidar M A; Kantarjian H; Manshouri T; Chang C Y; O'Brien S; Freireich E; Keating M; Albitar M
ATM gene deletion in patients with adult acute lymphoblastic leukemia.
Cancer 2000;88(5):1057-62.
2000: Haidar M A; Manshouri T; Keating M J; Kantarjian H M; Freireich E J; Mehta K; Albitar M
Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic mice.
International journal of oncology 2000;16(3):561-5.
2000: Keyhani A; Huh Y O; Jendiroba D; Pagliaro L; Cortez J; Pierce S; Pearlman M; Estey E; Kantarjian H; Freireich E J
Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.
Leukemia research 2000;24(2):153-9.
2000: Kantarjian H M; O'Brien S; Smith T L; Cortes J; Giles F J; Beran M; Pierce S; Huh Y; Andreeff M; Koller C; Ha C S; Keating M J; Murphy S; Freireich E J
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):547-61.
2000: Faber J; Kantarjian H; Roberts M W; Keating M; Freireich E; Albitar M
Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
Archives of pathology & laboratory medicine 2000;124(1):92-7.
1999: Estey E H; Giles F J; Kantarjian H; O'Brien S; Cortes J; Freireich E J; Lopez-Berestein G; Keating M
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.
Blood 1999;94(7):2230-5.
1999: Starostik P; O'Brien S; Chung C Y; Haidar M; Manshouri T; Kantarjian H; Freireich E; Keating M; Albitar M
The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia.
Leukemia research 1999;23(9):795-801.
1999: Aboul-Nasr R; Estey E H; Kantarjian H M; Freireich E J; Andreeff M; Johnson B J; Albitar M
Comparison of touch imprints with aspirate smears for evaluating bone marrow specimens.
American journal of clinical pathology 1999;111(6):753-8.
1999: Weinkauff R; Estey E H; Starostik P; Hayes K; Huh Y O; Hirsch-Ginsberg C; Andreeff M; Keating M; Kantarjian H M; Freireich E J; Albitar M
Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia.
American journal of clinical pathology 1999;111(6):733-40.
1999: O'Brien S; Kantarjian H; Koller C; Feldman E; Beran M; Andreeff M; Giralt S; Cheson B; Keating M; Freireich E; Rios M B; Talpaz M
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia.
Blood 1999;93(12):4149-53.
1999: Estey E H; Thall P F; Pierce S; Cortes J; Beran M; Kantarjian H; Keating M J; Andreeff M; Freireich E
Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Blood 1999;93(8):2478-84.
1999: Cortes J E; Kantarjian H M; O'Brien S; Giles F; Keating M J; Freireich E J; Estey E H
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.
Cancer 1999;85(7):1506-13.
1999: Albitar M; Manshouri T; Kantarjian H; Keating M; Estrov Z; Faber J; Freireich E J; Pierce S; Estey E
Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia.
Leukemia research 1999;23(1):63-9.
1998: Chandra J; Niemer I; Gilbreath J; Kliche K O; Andreeff M; Freireich E J; Keating M; McConkey D J
Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes.
Blood 1998;92(11):4220-9.
1998: Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
Cancer research 1998;58(20):4552-7.
1998: Cortes J; Talpaz M; O'Brien S; Rios M B; Majlis A; Keating M; Freireich E J; Kantarjian H
Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3279-85.
1998: Freireich E J
Four decades of therapy for AML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12 Suppl 1():S54-6.
1998: Pagliaro L C; Liu B; Munker R; Andreeff M; Freireich E J; Scheinberg D A; Rosenblum M G
Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1971-6.
1998: Jendiroba D B; Lichtiger B; Anaissie E; Reddy V; O'Brien S; Kantarjian H; Freireich E J
Evaluation and comparison of three mobilization methods for the collection of granulocytes.
Transfusion 1998;38(8):722-8.
1998: Keating M J; O'Brien S; Lerner S; Koller C; Beran M; Robertson L E; Freireich E J; Estey E; Kantarjian H
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.
Blood 1998;92(4):1165-71.
1997: Kantarjian H M; Talpaz M; O'Brien S; Kurzrock R; Gutterman J; Keating M J; McCredie K B; Freireich E J
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2723-33.
1997: Freireich E J
Who took the clinical out of clinical research?--Mouse versus man: seventh David A Karnofsky Memorial Lecture--1976.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2711-22.
1997: Freireich E J
The future of clinical cancer research in the next millennium.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2563-70.
1997: Freireich E J; Keating M J
Conclusions regarding leukemia long-term survival.
Cancer 1997;80(11 Suppl):2215-7.
1997: Estey E; deLima M; Strom S; Pierce S; Freireich E J; Keating M J
Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M.D. Anderson Cancer Center.
Cancer 1997;80(11 Suppl):2176-80.
1997: de Lima M; Strom S S; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich E; Estey E
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work.
Blood 1997;90(12):4719-24.
1997: Chandra J; Gilbreath J; Freireich E J; Kliche K O; Andreeff M; Keating M; McConkey D J
Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes.
Blood 1997;90(9):3673-81.
1997: Dignani M C; Anaissie E J; Hester J P; O'Brien S; Vartivarian S E; Rex J H; Kantarjian H; Jendiroba D B; Lichtiger B; Andersson B S; Freireich E J
Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(10):1621-30.
1996: Ghaddar H M; Pierce S; Kantarjian H M; Freireich E J; Keating M J; Estey E H
Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.
Leukemia & lymphoma 1996;22(1-2):71-6.
1996: Anderlini P; Ghaddar H M; Smith T L; Pierce S; Kantarjian H M; O'Brien S; Keating M J; Freireich E J; Estey E H
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(6):964-9.
1995: Andersson B S; Collins V P; Kurzrock R; Larkin D W; Childs C; Ost A; Cork A; Trujillo J M; Freireich E J; Siciliano M J
KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(12):2100-8.
1995: Cortes J; O'Brien S M; Pierce S; Keating M J; Freireich E J; Kantarjian H M
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
Blood 1995;86(6):2091-7.
1995: Sen S; Zhou H; Andersson B S; Cork A; Freireich E J; Stass S A
p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Cancer genetics and cytogenetics 1995;82(1):35-40.
1995: Pagliaro L C; Antelman D; Johnson D E; Machemer T; McCulloch E A; Freireich E J; Stass S A; Shepard H M; Maneval D; Gutterman J U
Recombinant human retinoblastoma protein inhibits cancer cell growth.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(6):673-80.
1995: Cortes J E; Kantarjian H; O'Brien S; Keating M; Pierce S; Freireich E J; Estey E
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(1):115-7.
1995: Hester J P; Dignani M C; Anaissie E J; Kantarjian H M; O'Brien S; Freireich E J
Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection.
Journal of clinical apheresis 1995;10(4):188-93.
1994: Cortes J; O'Brien S; Kantarjian H; Cork A; Stass S; Freireich E J; Keating M; Pierce S; Estey E
Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(12):2174-8.
1994: Ghaddar H M; Plunkett W; Kantarjian H M; Pierce S; Freireich E J; Keating M J; Estey E H
Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(8):1269-74.
1994: Seymour J F; Kurzrock R; Freireich E J; Estey E H
2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia.
Blood 1994;83(10):2906-11.
1994: Kagan J; Joe Y S; Freireich E J
Joining of recombination signals on the der 14q- chromosome in T-cell acute leukemia with t(10;14) chromosome translocation.
Cancer research 1994;54(1):226-30.
1994: Maruyama F; Stass S A; Estey E H; Cork A; Hirano M; Ino T; Freireich E J; Yang P; Chang K S
Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(1):40-5.
1994: Freireich E J
Detection of minimal residual disease in acute myeloblastic leukemia.
Progress in clinical and biological research 1994;389():579-85.
1993: Maruyama F; Yang P; Stass S A; Cork A; Freireich E J; Lee M S; Chang K S
Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia.
Cancer research 1993;53(19):4449-51.
1993: Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich E J; Andersson B S; O'Brien S; Andreeff M; Fisher H; Cork A
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
The New England journal of medicine 1993;329(11):757-61.
1993: Sen S; Takahashi R; Rani S; Freireich E J; Stass S A
Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines.
Leukemia research 1993;17(8):639-47.
1993: Keating M J; O'Brien S; Kantarjian H; Plunkett W; Estey E; Koller C; Beran M; Freireich E J
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent.
Blood 1993;81(11):2878-84.
1993: Dimopoulos M A; Kantarjian H; Estey E; O'Brien S; Delasalle K; Keating M J; Freireich E J; Alexanian R
Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine.
Annals of internal medicine 1993;118(3):195-8.
1993: Freireich E J
White cell transfusions born again.
Leukemia & lymphoma 1993;11 Suppl 2():161-5.
1992: Lee M; Khouri I; Champlin R; Kantarjian H; Talpaz M; Trujillo J; Freireich E; Deisseroth A; Stass S
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.
British journal of haematology 1992;82(4):708-14.
1992: Freireich E J
Impact of cytogenetics and molecular genetics on leukemia therapy.
The Mount Sinai journal of medicine, New York 1992;59(5):396-9.
1992: O'Brien S; Kantarjian H; Freireich E; Johnston D; Nguyen K; Beran M
CI-973, a new platinum derivative with potential antileukemic activity.
Cancer research 1992;52(15):4130-4.
1992: Freireich E J; Cork A; Stass S A; McCredie K B; Keating M J; Estey E H; Kantarjian H M; Trujillo J M
Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(6):500-6.
1992: Lee M S; Kantarjian H; Talpaz M; Freireich E J; Deisseroth A; Trujillo J M; Stass S A
Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy.
Blood 1992;79(8):1920-3.
1992: Chang K S; Wang G; Freireich E J; Daly M; Naylor S L; Trujillo J M; Stass S A
Specific expression of the annexin VIII gene in acute promyelocytic leukemia.
Blood 1992;79(7):1802-10.
1992: Chang K S; Stass S A; Chu D T; Deaven L L; Trujillo J M; Freireich E J
Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia.
Molecular and cellular biology 1992;12(2):800-10.
1992: Chang K S; Lu J F; Wang G; Trujillo J M; Estey E; Cork A; Chu D T; Freireich E J; Stass S A
The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction.
Blood 1992;79(3):554-8.
1992: Estey E; Trujillo J M; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich E J; Stass S
AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Hematologic pathology 1992;6(1):43-8.
1992: Keating M J; Estey E; Kantarjian H; Plunkett W; O'Brien S; Koller C; Beran M; Freireich E J
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():78-80.
1991: Kantarjian H M; Talpaz M; Keating M J; Estey E H; O'Brien S; Beran M; McCredie K B; Gutterman J; Freireich E J
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cancer 1991;68(6):1201-7.
1991: Kurzrock R; Talpaz M; Gomez J A; Estey E H; O'Brien S; Hirsch-Ginsberg C; Koller C; Freireich E J; Gutterman J U
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients.
British journal of haematology 1991;78(3):352-8.
1991: Chang K S; Zhao S R; Wang Y P; Lu J F; Trujillo J M; Stass S A; Freireich E J
Down regulation of myeloperoxidase gene associated with specific nuclease hypersensitive sites during TPA induced differentiation of HL-60.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(3):205-9.
1991: Chang K S; Trujillo J M; Ogura T; Castiglione C M; Kidd K K; Zhao S R; Freireich E J; Stass S A
Rearrangement of the retinoic acid receptor gene in acute promyelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(3):200-4.
1991: Keating M J; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs C C; Freireich E J; McCredie K B
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(1):44-9.
1991: Lotzová E; Savary C A; Totpal K; Schachner J; Lichtiger B; McCredie K B; Freireich E J
Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia.
Leukemia research 1991;15(4):245-54.
1990: Walters R; Kantarjian H M; Keating M J; Estey E H; Trujillo J; Cork A; McCredie K B; Freireich E J
The importance of cytogenetic studies in adult acute lymphocytic leukemia.
The American journal of medicine 1990;89(5):579-87.
1990: Hirsch-Ginsberg C; LeMaistre A C; Kantarjian H; Talpaz M; Cork A; Freireich E J; Trujillo J M; Lee M S; Stass S A
RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.
Blood 1990;76(6):1214-9.
1990: Kantarjian H M; Hirsch-Ginsberg C; Yee G; Huh Y; Freireich E J; Stass S
Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy.
Blood 1990;76(4):808-13.
1990: Chang K S; Trujillo J M; Pugh W C; Freireich E J; Stass S A
Developmental and differential regulation of human MPO gene in leukemic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(7):497-501.
1990: Savary C A; Lotzová E; Lichtiger B; Freireich E J
Enrichment of oncolytic cells for adoptive therapy using centrifugal elutriation.
Journal of clinical & laboratory immunology 1990;32(3):123-9.
1990: Estey E H; Dixon D; Kantarjian H M; Keating M J; McCredie K; Bodey G P; Kurzrock R; Talpaz M; Freireich E J; Deisseroth A B
Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1990;75(9):1766-9.
1990: Estey E H; Keating M J; McCredie K B; Freireich E J; Plunkett W
Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(2):95-9.
1990: Skinner W L; Murray D; Kohli V; Beran M; McCredie K B; Freireich E J; Andersson B S
Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia.
British journal of cancer 1990;61(1):51-5.
1990: Kantarjian H M; Walters R L; Keating M J; Estey E H; O'Brien S; Schachner J; McCredie K B; Freireich E J
Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia.
Cancer 1990;65(1):5-8.
1989: Childs C C; Hirsch-Ginsberg C; Walters R S; Andersson B S; Reuben J; Trujillo J M; Cork A; Stass S A; Freireich E J; Zipf T F
Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(11):777-83.
1989: Gagnon G A; Childs C C; LeMaistre A; Keating M; Cork A; Trujillo J M; Nellis K; Freireich E; Stass S A
Molecular heterogeneity in acute leukemia lineage switch.
Blood 1989;74(6):2088-95.
1989: Cason J D; Trujillo J M; Estey E H; Huh Y O; Freireich E J; Stass S A
Peripheral acute leukemia: high peripheral but low-marrow blast count.
Blood 1989;74(5):1758-61.
1989: Keating M J; Kantarjian H; Smith T L; Estey E; Walters R; Andersson B; Beran M; McCredie K B; Freireich E J
Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1071-80.
1989: Kantarjian H M; Walters R S; Keating M J; Barlogie B; McCredie K B; Freireich E J
Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.
Cancer 1989;64(1):16-22.
1989: Keating M J; Kantarjian H; Talpaz M; Redman J; Koller C; Barlogie B; Velasquez W; Plunkett W; Freireich E J; McCredie K B
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
Blood 1989;74(1):19-25.
1989: Lee M S; LeMaistre A; Kantarjian H M; Talpaz M; Freireich E J; Trujillo J M; Stass S A
Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction.
Blood 1989;73(8):2165-70.
1989: Estey E; Smith T L; Keating M J; McCredie K B; Gehan E A; Freireich E J
Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(4):257-63.
1989: Kantarjian H M; Keating M J; Walters R S; Koller C A; McCredie K B; Freireich E J
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia.
Cancer 1989;63(5):813-7.
1989: LeMaistre A; Lee M S; Talpaz M; Kantarjian H M; Freireich E J; Deisseroth A B; Trujillo J M; Stass S A
Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.
Blood 1989;73(4):889-91.
1988: Kantarjian H M; Shtalrid M; Kurzrock R; Blick M; Dalton W T; LeMaistre A; Stass S A; McCredie K B; Gutterman J; Freireich E J
Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
The American journal of medicine 1988;85(5):639-44.
1988: Kantarjian H M; Walters R S; Smith T L; Keating M J; Barlogie B; McCredie K B; Freireich E J
Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.
Blood 1988;72(5):1784-9.
1988: Schachner J; Kantarjian H; Dalton W; McCredie K; Keating M; Freireich E J
Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(10):667-71.
1988: Lee M S; Chang K S; Freireich E J; Kantarjian H M; Talpaz M; Trujillo J M; Stass S A
Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction.
Blood 1988;72(3):893-7.
1988: Keating M J; Smith T L; Kantarjian H; Cork A; Walters R; Trujillo J M; McCredie K B; Gehan E A; Freireich E J
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(7):403-12.
1988: Kantarjian H M; Dixon D; Keating M J; Talpaz M; Walters R S; McCredie K B; Freireich E J
Characteristics of accelerated disease in chronic myelogenous leukemia.
Cancer 1988;61(7):1441-6.
1988: Keating M J; Scouros M; Murphy S; Kantarjian H; Hester J; McCredie K B; Hersh E M; Freireich E J
Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(3):157-64.
1988: Kantarjian H M; Keating M J; Walters R S; McCredie K B; Freireich E J
The characteristics and outcome of patients with late relapse acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(2):232-8.
1988: Dalton W T; Ahearn M J; McCredie K B; Freireich E J; Stass S A; Trujillo J M
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3.
Blood 1988;71(1):242-7.
1988: Hirsch-Ginsberg C; Childs C; Chang K S; Beran M; Cork A; Reuben J; Freireich E J; Chang L C; Bollum F J; Trujillo J
Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia.
Blood 1988;71(1):186-95.
1988: Childs C C; Hirsch-Ginsberg C; Culbert S J; Ahearn M; Reuben J; Trujillo J M; Cork A; Walters R R; Freireich E J; Stass S A
Lineage heterogeneity in acute leukemia with the t(4;11) abnormality: implications for acute mixed lineage leukemia.
Hematologic pathology 1988;2(3):145-57.
1988: LeMaistre A; Childs C C; Hirsch-Ginsberg C; Reuben J; Cork A; Trujillo J M; Andersson B; McCredie K B; Freireich E; Stass S A
Heterogeneity in acute undifferentiated leukemia.
Hematologic pathology 1988;2(2):79-90.
1988: Freireich E J
The use of clinical data to predict response to therapy.
Progress in clinical and biological research 1988;276():227-35.
1987: Estey E H; Keating M J; McCredie K B; Freireich E J
Continuous-infusion amsacrine in patients with refractory acute myelogenous leukemia.
Cancer treatment reports 1987;71(11):1113-4.
1987: Dixon D O; McLaughlin P; Hagemeister F B; Freireich E J; Fuller L M; Cabanillas F F; Gehan E A
Reporting outcomes in Hodgkin's disease and lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1670-2.
1987: Kantarjian H M; Keating M J; McCredie K B; Walters R; Talpaz M; Smith T L; Freireich E J
Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia.
Southern medical journal 1987;80(10):1228-32.
1987: Walters R S; Kantarjian H M; Keating M J; Talpaz M; Childs C C; McCredie K B; Freireich E J
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron.
Cancer 1987;60(8):1708-12.
1987: Barlogie B; Stass S; Dixon D; Keating M; Cork A; Trujillo J M; McCredie K B; Freireich E J
DNA aneuploidy in adult acute leukemia.
Cancer genetics and cytogenetics 1987;28(2):213-28.
1987: Kantarjian H M; Keating M J; Talpaz M; Walters R S; Smith T L; Cork A; McCredie K B; Freireich E J
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
The American journal of medicine 1987;83(3):445-54.
1987: Estey E; Plunkett W; Dixon D; Keating M; McCredie K; Freireich E J
Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1987;1(8):580-3.
1987: Chang K S; Schroeder W; Siciliano M J; Thompson L H; McCredie K; Beran M; Freireich E J; Liang J C; Trujillo J M; Stass S A
The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1987;1(5):458-62.
1987: Beran M; Andersson B; Kantarjian H; Keating M; Rios A; McCredie K B; Freireich E J; Gutterman J
Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1987;1(1):52-7.
1987: Estey E H; Keating M J; Dixon D O; Trujillo J M; McCredie K B; Freireich E J
Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Hematologic pathology 1987;1(4):203-8.
1987: Dalton W T; Ahearn M J; Cork A; Trujillo J M; Keating M J; McCredie K B; Freireich E J; Stass S A
Acute myelomonocytic leukemia associated with abnormalities of chromosome 16: a light and electron microscopic study.
Hematologic pathology 1987;1(2):105-12.
1987: Keating M J; Estey E; Kantarjian H M; Walters R; Smith T; McCredie K B; Freireich E J
Comparison of results of salvage therapy in adult acute myelogenous leukemia.
Acta haematologica 1987;78 Suppl 1():120-6.
1987: Freireich E J
New strategies in the management of acute leukemias.
Acta haematologica 1987;78 Suppl 1():116-9.
1987: Lee M S; Chang K S; Trujillo J M; McCredie K B; Keating M J; Freireich E J; Stass S A
T-cell receptor gamma chain gene rearrangement in acute myelogenous leukemia--evidence for lymphoid lineage prematurity.
Hematologic pathology 1987;1(2):93-8.
1987: Kantarjian H M; Talpaz M; Kurzrock R; Keating M J; McCredie K B; Gutterman J; Freireich E J
Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemia.
Acta haematologica 1987;78 Suppl 1():70-4.
1986: Kantarjian H M; Keating M J; Walters R S; Estey E H; McCredie K B; Smith T L; Dalton W T; Cork A; Trujillo J M; Freireich E J
Acute promyelocytic leukemia. M.D. Anderson Hospital experience.
The American journal of medicine 1986;80(5):789-97.
1985: Maddox A M; Johnston D A; Barlogie B; Youness E; Keating M; Freireich E J
DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(6):799-808.
1985: Holmes R; Keating M J; Cork A; Broach Y; Trujillo J; Dalton W T; McCredie K B; Freireich E J
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22).
Blood 1985;65(5):1071-8.
1983: Maddox A M; Keating M J; Trujillo J; Cork A; Youness E; Ahearn M J; McCredie K B; Freireich E J
Philadelphia chromosome-positive adult acute leukemia with monosomy of chromosome number seven: a subgroup with poor response to therapy.
Leukemia research 1983;7(4):509-22.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Emil Freireich

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Emil Freireich (preview)

All Publications